Chris Rundfeldt

Dr. Chris Rundfeldt looks back on 22 years of experience in drug development, with more than 13 years in pharmaceutical industry. He gained hands on experience in different fields of pharmacology including target validation, drug development, toxicology, and early clinical development. As co-founder and vice president pharmacology, he actively participated in the management buyout of Elbion AG, a biopharmaceutical company dedicated to the development of CNS active drugs and immune modulators. He was responsible for translation of pharmacological results and safety data into clinical study programs. In 1996 he obtained the German Board certification for Veterinary Pharmacology and Toxicology. In 2000, he was granted the venia legendi (Assistant Professor) for Veterinary Pharmacology and Toxicology at the Free University of Berlin. Since 2007, he has been working as independent drug development consultant and partner at DrugConsult.Net, a German development expert partnership.

1books edited

Latest work with IntechOpen by Chris Rundfeldt

This book represents a case study based overview of many different aspects of drug development, ranging from target identification and characterization to chemical optimization for efficacy and safety, as well as bioproduction of natural products utilizing for example lichen. In the last section, special aspects of the formal drug development process are discussed. Since drug development is a highly complex multidisciplinary process, case studies are an excellent tool to obtain insight in this field. While each chapter gives specific insight and may be read as an independent source of information, the whole book represents a unique collection of different facets giving insight in the complexity of drug development.

Go to the book